Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
| Descriptor ID |
D004359
|
| MeSH Number(s) |
E02.319.310
|
| Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 18 | 18 |
| 1997 | 1 | 18 | 19 |
| 1998 | 2 | 14 | 16 |
| 1999 | 1 | 12 | 13 |
| 2000 | 1 | 12 | 13 |
| 2001 | 0 | 12 | 12 |
| 2002 | 1 | 18 | 19 |
| 2003 | 4 | 37 | 41 |
| 2004 | 3 | 29 | 32 |
| 2005 | 0 | 23 | 23 |
| 2006 | 0 | 27 | 27 |
| 2007 | 0 | 26 | 26 |
| 2008 | 0 | 32 | 32 |
| 2009 | 0 | 40 | 40 |
| 2010 | 0 | 29 | 29 |
| 2011 | 2 | 42 | 44 |
| 2012 | 1 | 36 | 37 |
| 2013 | 1 | 33 | 34 |
| 2014 | 0 | 36 | 36 |
| 2015 | 1 | 35 | 36 |
| 2016 | 0 | 34 | 34 |
| 2017 | 0 | 36 | 36 |
| 2018 | 4 | 41 | 45 |
| 2019 | 1 | 37 | 38 |
| 2020 | 1 | 38 | 39 |
| 2021 | 0 | 17 | 17 |
| 2022 | 1 | 10 | 11 |
| 2023 | 1 | 16 | 17 |
| 2024 | 3 | 18 | 21 |
| 2025 | 0 | 21 | 21 |
| 2026 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Mitragynine and naltrexone alone and in combination reduce alcohol self-administration in female Sprague Dawley rats. Drug Alcohol Depend. 2026 Jun 01; 283:113126.
-
Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease. JACC Cardiovasc Imaging. 2026 Apr; 19(4):516-534.
-
Patiromer utility as an adjunct treatment in patients needing urgent hyperkalaemia management (PLATINUM): a randomised controlled trial in the emergency department. BMJ Open. 2026 Feb 23; 16(2):e105103.
-
Comparative efficacy, safety and compliance with dual, triple and quadruple therapy as the first-line treatment regimens for Helicobacter pylori eradication: a systematic review and network meta-analysis. BMJ Open Gastroenterol. 2026 Jan 14; 13(1).
-
Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20?years, in Sub-Saharan Africa. Contemp Clin Trials. 2026 Mar; 162:108213.
-
Effective Management of a Rare Case of Pediatric ANCA-Associated Vasculitis With Rituximab and Mycophenolate Mofetil. Am J Case Rep. 2026 Jan 04; 27:e949274.
-
Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial). Sci Rep. 2025 Dec 18; 15(1):44105.
-
Eradication Rates of Empiric Helicobacter pylori Treatment Regimens by Race/Ethnicity in a Predominantly Immigrant U.S. Population. Helicobacter. 2025 Nov-Dec; 30(6):e70095.
-
Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial. JAMA. 2025 Oct 21; 334(15):1339-1348.
-
Duration of Concurrent Oxycodone and Selective Serotonin Reuptake Inhibitors Use and the Risk of Opioid Overdose. Ann Pharmacother. 2026 May; 60(5):425-434.